linalool has been researched along with paclitaxel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katsuyama, S; Kishikawa, Y; Komatsu, T; Kuwahata, H; Nakamura, H; Sakurada, T; Yagi, T | 1 |
| Bae, DS; Byeon, Y; Cho, SK; Cho, YJ; Han, HD; Jeon, HN; Kim, BG; Kim, HS; Lee, JW; Lopez-Berestein, G; Park, YM; Shin, BC; Sood, AK | 1 |
2 other study(ies) available for linalool and paclitaxel
| Article | Year |
|---|---|
Intraplantar injection of linalool reduces paclitaxel-induced acute pain in mice.
Topics: Acute Pain; Acyclic Monoterpenes; Animals; Antineoplastic Agents, Phytogenic; Drosophila Proteins; Hyperalgesia; Injections; Male; Mice; Monoterpenes; Naloxone; Narcotic Antagonists; Paclitaxel; Protein Serine-Threonine Kinases | 2012 |
Linalool-Incorporated Nanoparticles as a Novel Anticancer Agent for Epithelial Ovarian Carcinoma.
Topics: Acyclic Monoterpenes; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Membrane Potential, Mitochondrial; Mice; Monoterpenes; Nanoparticles; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Reactive Oxygen Species; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |